Alignment Healthcare Financials - Benzinga

Alignment Healthcare Inc

ALHCNASDAQ

Trade with Public

Trade with Public

$8.40

0.070.84%

마지막 업데이트: Sep 22, 9:18 AM

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 비교 옵션 주식 보고서

Alignment Healthcare Financials

Alignment Healthcare (ALHC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Alignment Healthcare Raises FY2026 Sales Guidance from $5.160B-$5.205B to $5.195B-$5.225B vs $5.189B Est

Alignment Healthcare (NASDAQ:ALHC) raises FY2026 sales outlook from $5.160 billion-$5.205 billion to $5.195 billion-$5.225 billion vs $5.189 billion estimate.

Benzinga Newsdesk

PRO
Alignment Healthcare Sees Q3 Sales $1.300B-$1.320B vs $1.315B Est

Alignment Healthcare (NASDAQ:ALHC) sees Q3 sales of $1.300 billion-$1.320 billion vs $1.315 billion analyst estimate.

Benzinga Newsdesk

PRO
Alignment Healthcare Q2 EPS $0.17 Beats $0.13 Estimate, Sales $1.336B Beat $1.310B Estimate

Alignment Healthcare (NASDAQ:ALHC) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.13 by 30.77 percent. This is a 112.5 percent increase over earnings of $0.08 per share

Benzinga Newsdesk

PRO
Alignment Healthcare Sees Q2 Sales $1.295B-$1.315B vs $1.315B Est

Alignment Healthcare (NASDAQ:ALHC) sees Q2 sales of $1.295 billion-$1.315 billion vs $1.315 billion analyst estimate.

Benzinga Newsdesk

PRO
Alignment Healthcare Raises FY2026 Sales Guidance from $5.135B-$5.190B to $5.160B-$5.205B vs $5.173B Est

Alignment Healthcare (NASDAQ:ALHC) raises FY2026 sales outlook from $5.135 billion-$5.190 billion to $5.160 billion-$5.205 billion vs $5.173 billion estimate.

Benzinga Newsdesk

PRO
Alignment Healthcare Q1 EPS $0.05 Beats $0.01 Estimate, Sales $1.235B Beat $1.218B Estimate

Alignment Healthcare (NASDAQ:ALHC) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.01 by 400 percent. This is a 200 percent increase over losses of $(0.05) per share from

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved